Quintiles Phase One Clinical Trials India Profile
Key Indicators
- Authorised Capital ₹ 38.00 Cr
- Paid Up Capital ₹ 36.57 Cr
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth -95.71%
- Profit Growth -170.66%
- Ebitda -266.59%
- Net Worth -51.44%
- Total Assets -1.51%
About Quintiles Phase One Clinical Trials India
Quintiles Phase One Clinical Trials India Private Limited (QPOCTIPL) is Dissolved (Liquidated) company established on 03 Jul 2009 with its office registered at Hyderabad, Telangana, India and has been running since 15 Year, 8 Months with a paid up capital of 36.57 Cr. According to MCA records, 3 Directors and 1 Signatories are linked to this company as of 16 Jan 2025.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100TG2009FTC064239
- Company No.
064239
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
03 Jul 2009
- Date of AGM
29 Jun 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Healthcare
Quintiles Phase One Clinical Trials India Private Limited
Explore comprehensive data for Quintiles Phase One Clinical Trials India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Quintiles Phase One Clinical Trials India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Khusboo Singhvi | Company Secretary | 24-Apr-2019 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilanjan Sinha  | Director | 14-Nov-2016 | Current |
| Arjun Aiyar | Director | 01-Nov-2016 | Current |
| Haripprasad Kovalamuri | Director | 15-May-2013 | Current |
Financial Performance of Quintiles Phase One Clinical Trials India.
Quintiles Phase One Clinical Trials India Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 95.71% decrease. The company also saw a substantial fall in profitability, with a 170.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 51.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quintiles Phase One Clinical Trials India?
In 2017, Quintiles Phase One Clinical Trials India had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Excel Life Sciences Private LimitedArjun Aiyar and Nilanjan Sinha are mutual person
Apokos Rehab Private LimitedHaripprasad Kovalamuri is a mutual person
Iqvia Rds (India) Private LimitedArjun Aiyar and Nilanjan Sinha are mutual person
- Iqvia Analytics Services Private Limited
Arjun Aiyar and Nilanjan Sinha are mutual person
Quality Care India LimitedHaripprasad Kovalamuri is a mutual person
Samudra Health Care Enterprises LimitedHaripprasad Kovalamuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quintiles Phase One Clinical Trials India?
Unlock and access historical data on people associated with Quintiles Phase One Clinical Trials India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quintiles Phase One Clinical Trials India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quintiles Phase One Clinical Trials India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Quintiles Phase One Clinical Trials India
Recent activity within the organization
- Annual General Meeting
Quintiles Phase One Clinical Trials India Private Limited last Annual general meeting of members was held on 29 Jun 2020 as per latest MCA records.
- Balance Sheet
Quintiles Phase One Clinical Trials India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
- Director Appointment
Khusboo Singhvi was appointed as a Company Secretary was appointed as a Company Secretary on 24 Apr 2019 & has been associated with this company since 5 years 10 months .
- Director Appointment
Nilanjan Sinha was appointed as a Director was appointed as a Director on 14 Nov 2016 & has been associated with this company since 8 years 4 months .
- Director Appointment
Arjun Aiyar was appointed as a Director was appointed as a Director on 01 Nov 2016 & has been associated with this company since 8 years 4 months .
- Director Appointment
Haripprasad Kovalamuri was appointed as a Director was appointed as a Director on 15 May 2013 & has been associated with this company since 11 years 10 months .
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Quintiles Phase One Clinical Trials India Private Limited?
Quintiles Phase One Clinical Trials India Private Limited was incorporated on 03 Jul 2009.
What is authorized share capital and paid-up capital of Quintiles Phase One Clinical Trials India Private Limited?
The authorized share capital of Quintiles Phase One Clinical Trials India Private Limited is ₹ 38.00 Cr and paid-up capital is ₹ 36.57 Cr.
Who are the current board members & directors of Quintiles Phase One Clinical Trials India Private Limited?
Currently 4 directors are associated with Quintiles Phase One Clinical Trials India Private Limited.
- Haripprasad Kovalamuri
- Arjun Aiyar
- Nilanjan Sinha
- Khusboo Singhvi
What is the registered address of Quintiles Phase One Clinical Trials India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Quintiles Phase One Clinical Trials India Private Limited is 7Th 8Th Floor Apollo Health Street Building City Behind Kbr Park, Jub Ilee Hills India, Hyderabad, Telangana, 500033.
What is the corporate identification number (CIN) and company number of Quintiles Phase One Clinical Trials India Private Limited?
The corporate identification number (CIN) of Quintiles Phase One Clinical Trials India Private Limited is U73100TG2009FTC064239 and the company number is 064239 as per Ministry of Corporate Affairs (MCA).
What is the official website of Quintiles Phase One Clinical Trials India Private Limited?
The Official website of Quintiles Phase One Clinical Trials India Private Limited is https://www.quintiles.com
What has been the recent revenue trend for Quintiles Phase One Clinical Trials India Private Limited?
According to the financial reports for the fiscal year 2016, the revenue trend for Quintiles Phase One Clinical Trials India Private Limited has fallen by -95.71%.
What change has been observed in the net worth of Quintiles Phase One Clinical Trials India Private Limited, and by what percentage?
The financial reports for the fiscal year 2016 indicates that The net worth of Quintiles Phase One Clinical Trials India Private Limited has experienced an downturn of -51.44%.
When was the last Balance Sheet of Quintiles Phase One Clinical Trials India Private Limited filed with the ROC?
The most recent Balance Sheet for Quintiles Phase One Clinical Trials India Private Limited was filed with the ROC on 31 Mar 2020.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Tushar TopraniAlternate DirectorSR
Suneeta ReddyDirectorSK
Shobana KamineniAlternate DirectorFE
Ferzaan EngineerDirectorRC
Ranjit ChaudhuryDirectorEC
Edward CaffreyDirectorOC
Oren CohenDirectorAK
Anil KumarDirector